Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study fromJapan
Authors:
- 27 October 2015
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 46 (8) , 734-742
Abstract
Aim: We investigated the characteristics and prognosis of patients with hepatocellular carcinoma (HCC) diagnosed after sustained virological response (SVR) to antiviral therapy for chronic hepatitis C virus (HCV) infection, namely, the eradication of HCV, according to surveillance status after SVR.Methods: In this multicenter study, liver function at HCC diagnosis and progression of HCC among patients with HCC diagnosed after SVR were compared. Outcomes were also investigated.Results: In patients not under surveillance after SVR, HCC was significantly more advanced at diagnosis, with tumors that were larger in size and of higher stage than in patients who continued under surveillance after SVR. Survival rates were significantly lower in patients not under surveillance (P < 0.0001). Among patients who were under surveillance, those with a 6‐month surveillance interval had larger and higher stage HCC than patients with a 3‐month interval. Recurrence rates in patients with a 6‐month surveillance interval were significantly higher than in patients with a 3‐month surveillance interval (P = 0.0417).Conclusion: Lack of surveillance after SVR was obviously associated with more advanced HCC at detection, resulting in poor prognosis. More importantly, there may be a difference in the severity of HCC at diagnosis and prognosis based on the surveillance interval after SVR. Establishing guidelines how to survey patients with chronic hepatitis C after SVR is necessary.Keywords
This publication has 33 references indexed in Scilit:
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicitiesHepatology, 2010
- A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C VirusClinical Gastroenterology and Hepatology, 2010
- Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelinesJournal of Gastroenterology, 2009
- ‘YES, NOW YOU ARE FREE FROM CHRONIC HCV INFECTION, BUT . . .’Journal of Gastroenterology and Hepatology, 2006
- Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapyJournal of Gastroenterology and Hepatology, 2005
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferonJournal of Gastroenterology, 2005
- Long‐term follow‐up of sustained responders to interferon therapy, in patients with chronic hepatitis CJournal of Viral Hepatitis, 2000
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data1973
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958